1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO